Refine Search
(117)
(365)
(507)
(529)

Diabetic Foot Ulcers - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Diabetic Foot Ulcers - Pipeline Review, H2 2018’, provides an overview of the Diabetic Foot Ulcers pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Diab...

Diabetic Neuropathy - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Diabetic Neuropathy - Pipeline Review, H2 2018’, provides an overview of the Diabetic Neuropathy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Diabet...

Radiodermatitis - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Radiodermatitis - Pipeline Review, H2 2018’, provides an overview of the Radiodermatitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Radiodermatiti...

Irritable Bowel Syndrome - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Irritable Bowel Syndrome - Pipeline Review, H2 2018’, provides an overview of the Irritable Bowel Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development ...

Gastritis - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Gastritis - Pipeline Review, H2 2018’, provides an overview of the Gastritis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Gastritis, complete with a...

Peritonitis - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Peritonitis - Pipeline Review, H2 2018’, provides an overview of the Peritonitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Peritonitis, complete ...

Systemic Mastocytosis - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Systemic Mastocytosis - Pipeline Review, H2 2018’, provides an overview of the Systemic Mastocytosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Sy...

Herpes Labialis (Oral Herpes) - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Herpes Labialis (Oral Herpes) - Pipeline Review, H2 2018’, provides an overview of the Herpes Labialis (Oral Herpes) pipeline landscape.

The report provides comprehensive information on the therapeutics under de...

Tularaemia - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Tularaemia - Pipeline Review, H2 2018’, provides an overview of the Tularaemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Tularaemia, complete wit...

Aspergillosis - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Aspergillosis - Pipeline Review, H2 2018’, provides an overview of the Aspergillosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Aspergillosis, com...

Cryptosporidiosis - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cryptosporidiosis - Pipeline Review, H2 2018’, provides an overview of the Cryptosporidiosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Cryptospor...

Progressive Multifocal Leukoencephalopathy - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Progressive Multifocal Leukoencephalopathy - Pipeline Review, H2 2018’, provides an overview of the Progressive Multifocal Leukoencephalopathy pipeline landscape.

The report provides comprehensive information on...

Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections - Pipeline Review, H2 2018’, provides an overview of the Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections pipeline landscape.

The re...

Benign Prostatic Hyperplasia - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Benign Prostatic Hyperplasia - Pipeline Review, H2 2018’, provides an overview of the Benign Prostatic Hyperplasia pipeline landscape.

The report provides comprehensive information on the therapeutics under deve...

Secondary (Hypogonadotropic) Hypogonadism - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Secondary (Hypogonadotropic) Hypogonadism - Pipeline Review, H2 2018’, provides an overview of the Secondary (Hypogonadotropic) Hypogonadism pipeline landscape.

The report provides comprehensive information on t...

Pemphigus Vulgaris - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pemphigus Vulgaris - Pipeline Review, H2 2018’, provides an overview of the Pemphigus Vulgaris pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pemphigu...

Lung Transplant Rejection - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Lung Transplant Rejection - Pipeline Review, H2 2018’, provides an overview of the Lung Transplant Rejection pipeline landscape.

The report provides comprehensive information on the therapeutics under developmen...

Anaphylaxis - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Anaphylaxis - Pipeline Review, H2 2018’, provides an overview of the Anaphylaxis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Anaphylaxis, complete ...

Homozygous Familial Hypercholesterolemia (HoFH) - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Homozygous Familial Hypercholesterolemia (HoFH) - Pipeline Review, H2 2018’, provides an overview of the Homozygous Familial Hypercholesterolemia (HoFH) pipeline landscape.

The report provides comprehensive info...

Heterozygous familial hypercholesterolemia (heFH) - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Heterozygous familial hypercholesterolemia (heFH) - Pipeline Review, H2 2018’, provides an overview of the Heterozygous familial hypercholesterolemia (heFH) pipeline landscape.

The report provides comprehensive ...

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline Review, H2 2018’, provides an overview of the End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) pipeline landscape.

The report provi...

Retinal Vein Occlusion - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Retinal Vein Occlusion - Pipeline Review, H2 2018’, provides an overview of the Retinal Vein Occlusion pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...

Macular Edema - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Macular Edema - Pipeline Review, H2 2018’, provides an overview of the Macular Edema pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Macular Edema, com...

Hemophilia A - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hemophilia A - Pipeline Review, H2 2018’, provides an overview of the Hemophilia A pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hemophilia A, comple...

Fanconi Anemia - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Fanconi Anemia - Pipeline Review, H2 2018’, provides an overview of the Fanconi Anemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Fanconi Anemia, ...

Hypereosinophilic Syndrome - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hypereosinophilic Syndrome - Pipeline Review, H2 2018’, provides an overview of the Hypereosinophilic Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under developm...

Aplastic Anemia - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Aplastic Anemia - Pipeline Review, H2 2018’, provides an overview of the Aplastic Anemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Aplastic Anemi...

Hypothyroidism - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hypothyroidism - Pipeline Review, H2 2018’, provides an overview of the Hypothyroidism pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hypothyroidism, ...

Hypoparathyroidism - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hypoparathyroidism - Pipeline Review, H2 2018’, provides an overview of the Hypoparathyroidism pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hypopara...

Hemochromatosis - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hemochromatosis - Pipeline Review, H2 2018’, provides an overview of the Hemochromatosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hemochromatosi...

Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) - Pipeline Review, H2 2018’, provides an overview of the Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) pipeline landscape....

Spinocerebellar Ataxia (SCA) - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Spinocerebellar Ataxia (SCA) - Pipeline Review, H2 2018’, provides an overview of the Spinocerebellar Ataxia (SCA) pipeline landscape.

The report provides comprehensive information on the therapeutics under deve...

Ulcerative Colitis - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Ulcerative Colitis - Pipeline Review, H2 2018’, provides an overview of the Ulcerative Colitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ulcerati...

Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2018’, provides an overview of the Human Papillomavirus (HPV) Associated Cancer pipeline landscape.

The report provides comprehensive informatio...

Asthma - Pipeline Review, H2 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Asthma - Pipeline Review, H2 2018’, provides an overview of the Asthma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Asthma, complete with analysis b...

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2018’, provides an overview of the Chronic Obstructive Pulmonary Disease (COPD) pipeline landscape.

The report provides comprehensive informatio...

Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2018’, provides an overview of the Idiopathic Pulmonary Fibrosis pipeline landscape.

The report provides comprehensive information on the therapeutics under de...

Schizophrenia - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Schizophrenia - Pipeline Review, H2 2018’, provides an overview of the Schizophrenia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Schizophrenia, com...

Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2018’, provides an overview of the Amyotrophic Lateral Sclerosis pipeline landscape.

The report provides comprehensive information on the therapeutics under de...

Acinetobacter Infections - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Acinetobacter Infections - Pipeline Review, H2 2018’, provides an overview of the Acinetobacter Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development ...

Neisseria meningitidis Infections - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Neisseria meningitidis Infections - Pipeline Review, H2 2018’, provides an overview of the Neisseria meningitidis Infections pipeline landscape.

The report provides comprehensive information on the therapeutics ...

Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline Review, H2 2018’, provides an overview of the Clostridium difficile Infections (Clostridium difficile Associated Disease) pipeline ...

Head And Neck Cancer - Pipeline Review, H2 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Head And Neck Cancer - Pipeline Review, H2 2018’, provides an overview of the Head And Neck Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Head...

Gastric Cancer - Pipeline Review, H2 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H2 2018’, provides an overview of the Gastric Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Gastric Cancer, ...

Bone Metastasis - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Bone Metastasis - Pipeline Review, H2 2018’, provides an overview of the Bone Metastasis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Bone Metastasi...

Fallopian Tube Cancer - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Fallopian Tube Cancer - Pipeline Review, H2 2018’, provides an overview of the Fallopian Tube Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Fa...

Oropharyngeal Cancer - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Oropharyngeal Cancer - Pipeline Review, H2 2018’, provides an overview of the Oropharyngeal Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Orop...

Peritoneal Cancer - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Peritoneal Cancer - Pipeline Review, H2 2018’, provides an overview of the Peritoneal Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Peritoneal...

Osteoporosis - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Osteoporosis - Pipeline Review, H2 2018’, provides an overview of the Osteoporosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Osteoporosis, comple...

Anesthetic Effect - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Anesthetic Effect - Pipeline Review, H2 2018’, provides an overview of the Anesthetic Effect pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Anesthetic...

Migraine - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Migraine - Pipeline Review, H2 2018’, provides an overview of the Migraine pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Migraine, complete with anal...

Klebsiella pneumoniae Infections - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Klebsiella pneumoniae Infections - Pipeline Review, H2 2018’, provides an overview of the Klebsiella pneumoniae Infections pipeline landscape.

The report provides comprehensive information on the therapeutics un...

Organophosphate and Carbamate Poisoning - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Organophosphate and Carbamate Poisoning - Pipeline Review, H2 2018’, provides an overview of the Organophosphate and Carbamate Poisoning pipeline landscape.

The report provides comprehensive information on the t...

Cancer Pain - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cancer Pain - Pipeline Review, H2 2018’, provides an overview of the Cancer Pain pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Cancer Pain, complete ...

Gastroenteritis - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Gastroenteritis - Pipeline Review, H2 2018’, provides an overview of the Gastroenteritis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Gastroenteriti...

Enterocolitis - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Enterocolitis - Pipeline Review, H2 2018’, provides an overview of the Enterocolitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Enterocolitis, com...

Eosinophilic Esophagitis - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Eosinophilic Esophagitis - Pipeline Review, H2 2018’, provides an overview of the Eosinophilic Esophagitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development ...

Rabies - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Rabies - Pipeline Review, H2 2018’, provides an overview of the Rabies pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Rabies, complete with analysis b...

Hepatitis A - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hepatitis A - Pipeline Review, H2 2018’, provides an overview of the Hepatitis A pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hepatitis A, complete ...

Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2018’, provides an overview of the Chagas Disease (American Trypanosomiasis) pipeline landscape.

The report provides comprehensive information on t...

Hepatitis D - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hepatitis D - Pipeline Review, H2 2018’, provides an overview of the Hepatitis D pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hepatitis D, complete ...

Japanese Encephalitis - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Japanese Encephalitis - Pipeline Review, H2 2018’, provides an overview of the Japanese Encephalitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ja...

Measles - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Measles - Pipeline Review, H2 2018’, provides an overview of the Measles pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Measles, complete with analysi...

Yellow Fever - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Yellow Fever - Pipeline Review, H2 2018’, provides an overview of the Yellow Fever pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Yellow Fever, comple...

Chikungunya Fever - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chikungunya Fever - Pipeline Review, H2 2018’, provides an overview of the Chikungunya Fever pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Chikunguny...

Rotavirus Infections - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Rotavirus Infections - Pipeline Review, H2 2018’, provides an overview of the Rotavirus Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Rota...

Haemophilus influenzae Type B Infections - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Haemophilus influenzae Type B Infections - Pipeline Review, H2 2018’, provides an overview of the Haemophilus influenzae Type B Infections pipeline landscape.

The report provides comprehensive information on the...

Premature Ejaculation - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Premature Ejaculation - Pipeline Review, H2 2018’, provides an overview of the Premature Ejaculation pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pr...

Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Thrombotic Thrombocytopenic Purpura - Pipeline Review, H2 2018’, provides an overview of the Thrombotic Thrombocytopenic Purpura pipeline landscape.

The report provides comprehensive information on the therapeut...

Inclusion Body Myositis (IBM) - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Inclusion Body Myositis (IBM) - Pipeline Review, H2 2018’, provides an overview of the Inclusion Body Myositis (IBM) pipeline landscape.

The report provides comprehensive information on the therapeutics under de...

Pheochromocytoma - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pheochromocytoma - Pipeline Review, H2 2018’, provides an overview of the Pheochromocytoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pheochromocy...

Essential Thrombocythemia - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Essential Thrombocythemia - Pipeline Review, H2 2018’, provides an overview of the Essential Thrombocythemia pipeline landscape.

The report provides comprehensive information on the therapeutics under developmen...

Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H2 2018’, provides an overview of the Basal Cell Carcinoma (Basal Cell Epithelioma) pipeline landscape.

The report provides comprehensive informat...

Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2018’, provides an overview of the Adrenocortical Carcinoma (Adrenal Cortex Cancer) pipeline landscape.

The report provides comprehensive in...

Retinoblastoma - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Retinoblastoma - Pipeline Review, H2 2018’, provides an overview of the Retinoblastoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Retinoblastoma, ...

Rhabdomyosarcoma - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Rhabdomyosarcoma - Pipeline Review, H2 2018’, provides an overview of the Rhabdomyosarcoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Rhabdomyosar...

Hairy Cell Leukemia - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hairy Cell Leukemia - Pipeline Review, H2 2018’, provides an overview of the Hairy Cell Leukemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hairy ...

Ureter Cancer - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Ureter Cancer - Pipeline Review, H2 2018’, provides an overview of the Ureter Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ureter Cancer, com...

Uveal Melanoma - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Uveal Melanoma - Pipeline Review, H2 2018’, provides an overview of the Uveal Melanoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Uveal Melanoma, ...

Bronchiectasis - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Bronchiectasis - Pipeline Review, H2 2018’, provides an overview of the Bronchiectasis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Bronchiectasis, ...

Women Infertility - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Women Infertility - Pipeline Review, H2 2018’, provides an overview of the Women Infertility pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Women Infe...

Premenstrual Syndrome - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Premenstrual Syndrome - Pipeline Review, H2 2018’, provides an overview of the Premenstrual Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pr...

Female Hypoactive Sexual Desire Disorder - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Female Hypoactive Sexual Desire Disorder - Pipeline Review, H2 2018’, provides an overview of the Female Hypoactive Sexual Desire Disorder pipeline landscape.

The report provides comprehensive information on the...

Kidney Transplant Rejection - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Kidney Transplant Rejection - Pipeline Review, H2 2018’, provides an overview of the Kidney Transplant Rejection pipeline landscape.

The report provides comprehensive information on the therapeutics under develo...

Peanut Allergy - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Peanut Allergy - Pipeline Review, H2 2018’, provides an overview of the Peanut Allergy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Peanut Allergy, ...

Post Menopausal Osteoporosis - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Post Menopausal Osteoporosis - Pipeline Review, H2 2018’, provides an overview of the Post Menopausal Osteoporosis pipeline landscape.

The report provides comprehensive information on the therapeutics under deve...

Pompe Disease - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pompe Disease - Pipeline Review, H2 2018’, provides an overview of the Pompe Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pompe Disease, com...

Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H2 2018’, provides an overview of the Chronic Kidney Disease (Chronic Renal Failure) pipeline landscape.

The report provides comprehensive inform...

Overactive Bladder - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Overactive Bladder - Pipeline Review, H2 2018’, provides an overview of the Overactive Bladder pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Overacti...

Kidney Fibrosis - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Kidney Fibrosis - Pipeline Review, H2 2018’, provides an overview of the Kidney Fibrosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Kidney Fibrosi...

Allergic Conjunctivitis - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Allergic Conjunctivitis - Pipeline Review, H2 2018’, provides an overview of the Allergic Conjunctivitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development fo...

Corneal Neovascularization - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Corneal Neovascularization - Pipeline Review, H2 2018’, provides an overview of the Corneal Neovascularization pipeline landscape.

The report provides comprehensive information on the therapeutics under developm...

Cataract - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cataract - Pipeline Review, H2 2018’, provides an overview of the Cataract pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Cataract, complete with anal...

Keratitis - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Keratitis - Pipeline Review, H2 2018’, provides an overview of the Keratitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Keratitis, complete with a...

Optic Neuritis - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Optic Neuritis - Pipeline Review, H2 2018’, provides an overview of the Optic Neuritis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Optic Neuritis, ...

Sickle Cell Disease - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Sickle Cell Disease - Pipeline Review, H2 2018’, provides an overview of the Sickle Cell Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Sickle...

Acne Vulgaris - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Acne Vulgaris - Pipeline Review, H2 2018’, provides an overview of the Acne Vulgaris pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Acne Vulgaris, com...

Rosacea - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Rosacea - Pipeline Review, H2 2018’, provides an overview of the Rosacea pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Rosacea, complete with analysi...

Chronic Urticaria Or Hives - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chronic Urticaria Or Hives - Pipeline Review, H2 2018’, provides an overview of the Chronic Urticaria Or Hives pipeline landscape.

The report provides comprehensive information on the therapeutics under developm...

Epidermolysis Bullosa - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Epidermolysis Bullosa - Pipeline Review, H2 2018’, provides an overview of the Epidermolysis Bullosa pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ep...